REAL-WORLD IMPACT OF TRIPLE THERAPY WITH FLUTICASONE FUROATE, UMECLIDINIUM, AND VILANTEROL ON ASTHMA CONTROL AMONG US PATIENTS WITH ASTHMA

被引：0
|
作者：
Bogart, Michael
Germain, Guillaume
Laliberte, Frakois
Mahendran, Malena
Duh, Mei S.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1598
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1930A / 1931A
页数：2
相关论文
共 50 条
  • [21] Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with Asthma
    Yahiya Y. Syed
    Drugs, 2015, 75 : 407 - 418
  • [22] InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis o the Western Europe and North America Regions
    Bourdin, Arnaud
    Criner, Gerard
    Devouassoux, Gilles
    Dransfield, Mark
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kalhan, Ravi
    Lange, Peter
    Lettis, Sally
    Lipson, David A.
    Lomas, David A.
    Maria-Tome, Jose M. Echave-Sustaeta
    Martin, Neil
    Martinez, Fernando J.
    Quasny, Holly
    Sail, Lynda
    Siler, Thomas M.
    Singh, Dave
    Thomashow, Byron
    Watz, Henrik
    Wise, Robert
    Hanania, Nicola A.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (01): : 76 - 90
  • [23] Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with Asthma
    Syed, Yahiya Y.
    DRUGS, 2015, 75 (04) : 407 - 418
  • [24] Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study
    Nakamura, Yoichi
    Hozawa, Soichiro
    Sagara, Hironori
    Ohbayashi, Hiroyuki
    Lee, Laurie A.
    Crawford, Jodie
    Tamaoki, Jun
    Nishi, Takanobu
    Fowler, Andrew
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1657 - 1665
  • [25] Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea
    Cho, Eun-Yeong
    Cho, Jung-Eun
    Jang, Seung Hun
    Hwang, Ki-Eun
    DRUG SAFETY, 2023, 46 (10) : 951 - 960
  • [26] Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea
    Eun-Yeong Cho
    Jung-Eun Cho
    Seung Hun Jang
    Ki-Eun Hwang
    Drug Safety, 2023, 46 : 951 - 960
  • [27] CAPTAIN STUDY: EFFECTS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ON FEV1 IMPROVEMENT IN ASTHMA ACCORDING TO AGE
    Hanania, N.
    Bailes, Z.
    Barnes, N.
    Gardiner, F.
    Lugogo, N.
    Mannino, D.
    Mehta, V.
    Nyanjom, D.
    Sitz, K.
    Kerstjens, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S28 - S28
  • [28] CAPTAIN STUDY: TREATMENT OUTCOMES FROM FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ACCORDING TO HISTORY OF SEVERE ASTHMA EXACERBATIONS
    Oppenheimer, J.
    Brusselle, G.
    Busse, W.
    Fowler, A.
    Jain, N.
    Mannino, D.
    Pavord, I.
    Win, P.
    Zarankaite, A.
    Kerwin, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S26 - S27
  • [29] Responder Rate Analysis Of Asthma Control Questionnaire Scores In Patients Treated With Once-Daily Fluticasone Furoate/Vilanterol Or Fluticasone Furoate
    Poor, C.
    Faison, S.
    Sutton, L.
    Stempel, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] Real-World Effectiveness of Fluticasone Furoate/ Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial
    Beeh, Kai -Michael
    Scheithe, Karl
    Schmutzler, Heike
    Krueger, Saskia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 205 - 216
12345